A Randomized Placebo-Controlled Trial of Citalopram for Anxiety Disorders Following Traumatic Brain Injury

Abstract

The overarching goal of this project is to study the effects of a serotonin reuptake inhibitor (SRI), citalopram, for the treatment of anxiety experienced by individuals after traumatic brain injury (TBI). Specifically, this project seeks to treat individuals who meet criteria for DSM-IV diagnosis of Anxiety Disorder Due to a General Medical Condition, within 3 to 24 months of TBI. A randomized placebo controlled design with 1-year follow-up will be utilized to evaluate the effectiveness of citalopram in alleviating significant anxiety symptoms that cause significant distress and can lead to medical retirement of active duty soldiers.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Apr 01, 2007
Accession Number
ADA471001

Entities

People

  • Deborah L. Warden

Organizations

  • Henry M. Jackson Foundation for the Advancement of Military Medicine

Tags

DTIC Thesaurus Topics

  • Active Duty
  • Anxiety Disorders
  • Biomedical Research
  • Brain
  • Brain Injuries
  • Department Of Defense
  • Diseases And Disorders
  • Electronic Mail
  • Health Services
  • Information Operations
  • Military Hospitals
  • Military Medicine
  • Nitriles
  • Test And Evaluation

Fields of Study

  • Medicine

Readers

  • Clinical Trial Research.
  • Psychological Intervention/Treatment for Stress, Anxiety, PTSD, and Related Emotional and Cognitive Health Symptoms.